JAPAN was the scene of a press conference for the General Incorporated Association Vaccine Issues Study Group in that Asian nation of 125.7 million, and the world’s third largest economy as measured by gross domestic product. A major pharmaceutical market, the Japanese group’s January 11, 2024, event centered around a concerted, systematic review of the medical literature covering COVID-19 vaccines. Professor Emeritus Masanori Fukushima, M.D., Ph.D., from Kyoto University cites the database of studies made possible by patient advocacy group React19 along with the TrialSite partnership to continuously promote the existence of a large body of peer-reviewed medical literature tracking adverse side effects, some of them injury causes, associated to the COVID-19 countermeasure program. The Japanese event occurred January 11, 2024.
The COVID-19 vaccines side effects can adversely impact every organ across the human body as more data supports the spike protein hypothesis. That is, that the mRNA induced spike protein can persist and travel in the human body for not only weeks, but months and even years.
Apparently, Japanese volunteer physicians have been amassing their own study hub, a set of documents derived from peer review case studies to more comprehensive population studies.
Substacker Aussie17 circulated the video snippet across the internet but few media picked up the event.
Ongoing medical censorship, according to the press conference, hinders physicians attempting to find ways to collaborate and care for patients. Then there’s the societal pressure, much like what we are experiencing in North America and Europe applying subtle and not so subtle pressure against any critical discussion about the COVID-19 vaccines, including vetting of mRNA-based vaccine injuries.
The participants also raised the specter of censorship at the level of scientific and medical journals, a phenomenon TrialSite has chronicled throughout the pandemic. TrialSite observed such censorship first with the discussion of alternative repurposed drugs such as ivermectin, then this same intuitive applied to critical discussion of the COVID-19 vaccines, or countermeasures as they are formally called by the U.S. government.
Professor Yasufumi Murakami went on the record at the event concerning adverse events, “One thing I want to say initially is that it is clear how the adverse effects occur, which is still holding many victims today. I believe it should be stopped immediately.”
Back to the spike protein hypothesis, not even acknowledged by the medical establishment in the developed nations, a mechanism of action now well understood, documented in multiple peer-reviewed studies and a recognition that the spike protein can at least in some cases circulate In the human body acting as an irritant with toxic impact.
Masanori Fukushima, M.D., Ph.D.
Also problematic, at least for some patients, is the mRNA vaccines’ lipid nanoparticles (LNP), which can induce toxic reactions as well.
TrialSite reviewed and verified the General Incorporated “Association Vaccine Issues Study Group” and its press conference to discuss its report on six-month results.
Follow the link to listen to various testimonies such as from Professor Emeritus Masanori Fukushima from Kyoto University.
Follow the link to the React19 study hub as well another version of the study list stored by CrossTx.
Sources: TS News